IntelliSyn

Envision Pharma Group acquires doDOC to enable seamless document collaboration as part of iEnvision, its global medical affairs platform

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Envision Pharma Group, regarding the acquisition of doDOC.  Envision Pharma Group (“Envision” or the “Company”), a leading global technology-enabled scientific communications company, is pleased to announce the acquisition of doDOC Corp., a… read more

GHO appoints David W. Miller and Geoffrey Hamilton-Fairley as Operating Partners

Appointments will support GHO through deal origination and portfolio company support, bringing extensive experience in market access, MedTech and advanced therapies from industry and consulting careers. London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, announces the appointment of David Miller and Geoffrey Hamilton-Fairley as Operating Partners.… read more

X-Chem acquires IntelliSyn and sister company, AviSyn, to extend and streamline drug discovery service range

Acquisition allows X-Chem to offer a more comprehensive, integrated, screen-to-lead drug discovery process to pharma and biotech clients IntelliSyn’s Founder and CEO Jeffrey Albert to join X-Chem management team London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, X-Chem, regarding… read more

Subscribe to our email alerts

Email updates